We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.27B
AUM Growth
+$187M
Cap. Flow
-$201M
Cap. Flow %
-2.17%
Top 10 Hldgs %
8.81%
Holding
1,234
New
57
Increased
340
Reduced
328
Closed
245

Top Buys

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$18.1M
2
PLMR icon
Palomar
PLMR
+$13.4M
3
GCMG icon
GCM Grosvenor
GCMG
+$12.9M
4
ACA icon
Arcosa
ACA
+$11.8M
5
MIDD icon
Middleby
MIDD
+$10.2M

Sector Composition

Rank Sector Weight
1 Industrials 24.2%
2 Technology 21.11%
3 Financials 13.34%
4 Consumer Discretionary 12.55%
5 Healthcare 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBLU icon
251
JetBlue
JBLU
$2.28B
$11.2M 0.12%
992,767
+410,267
+70% +$4.6M
CLDR
252
DELISTED
Cloudera, Inc.
CLDR
$11.2M 0.12%
1,029,754
+72,654
+8% +$842K
PRIM icon
253
Primoris Services
PRIM
$4.58B
$11.2M 0.12%
620,208
-5,398
-0.9% -$95.5K
OFIX icon
254
Orthofix Medical
OFIX
$477M
$11.2M 0.12%
358,202
+57,787
+19% +$1.79M
CCRN
255
DELISTED
Cross Country Healthcare
CCRN
$11.1M 0.12%
1,708,955
+45,342
+3% +$287K
SANM icon
256
Sanmina
SANM
$9.95B
$11M 0.12%
408,361
-14,316
-3% -$390K
ARCB icon
257
ArcBest
ARCB
$3.23B
$11M 0.12%
354,935
-75,488
-18% -$2.35M
LTHM
258
DELISTED
Livent Corporation
LTHM
$11M 0.12%
1,224,115
+7,878
+0.6% +$59.3K
LDL
259
DELISTED
Lydall, Inc.
LDL
$10.9M 0.12%
659,984
+21,861
+3% +$380K
SPB icon
260
Spectrum Brands
SPB
$2.04B
$10.9M 0.12%
190,797
+60,370
+46% +$3.31M
SAIA icon
261
Saia
SAIA
$9.25B
$10.9M 0.12%
86,321
-51,161
-37% -$6.53M
KIDS icon
262
OrthoPediatrics
KIDS
$519M
$10.8M 0.12%
234,800
+119,300
+103% +$5.53M
AMKR icon
263
Amkor Technology
AMKR
$12.4B
$10.8M 0.12%
961,719
+14,600
+2% +$181K
VLY icon
264
Valley National Bancorp
VLY
$7.9B
$10.8M 0.12%
1,569,675
+320,803
+26% +$2.38M
MLI icon
265
Mueller Industries
MLI
$14.7B
$10.7M 0.12%
1,584,804
+346,828
+28% +$2.48M
PBI icon
266
Pitney Bowes
PBI
$2.37B
$10.7M 0.12%
2,018,284
+312,500
+18% +$1.44M
EVBG
267
DELISTED
Everbridge, Inc. Common Stock
EVBG
$10.6M 0.11%
84,400
+5,000
+6% +$678K
OLN icon
268
Olin
OLN
$2.11B
$10.6M 0.11%
855,860
+188,444
+28% +$2.18M
FBIN icon
269
Fortune Brands Innovations
FBIN
$5.88B
$10.5M 0.11%
141,458
-20,758
-13% -$1.39M
UPWK icon
270
Upwork
UPWK
$1.13B
$10.4M 0.11%
598,460
NVGS icon
271
Navigator Holdings
NVGS
$1.38B
$10.4M 0.11%
1,244,481
+24,500
+2% +$204K
ITI
272
DELISTED
Iteris, Inc.
ITI
$10.3M 0.11%
2,519,705
+226,000
+10% +$1.05M
IVC
273
DELISTED
Invacare Corporation
IVC
$10.3M 0.11%
1,372,532
-15,000
-1% -$104K
GLDD
274
DELISTED
Great Lakes Dredge & Dock
GLDD
$10.3M 0.11%
1,083,046
+203,694
+23% +$1.87M
WPRT
275
Westport Fuel Systems
WPRT
$33.4M
$10.2M 0.11%
626,945
-7,501
-1% -$124K

Similar funds

Royce & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Royce & Associates held 1,234 positions worth $9.27B, up 2.1% from $9.08B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates's Q3 2020 filing shows 57 new, 340 increased, 328 reduced and 245 closed positions. Its largest new stake was Palomar: 136,247 shares worth $14.2M. The largest sale was Ares Management, an estimated $36.8M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2020 buy was Palomar: 136,247 shares worth $14.2M.
  • Royce & Associates added most to John B. Sanfilippo & Son in Q3 2020, an estimated $18.1M increase.
  • Royce & Associates's biggest Q3 2020 reduction was Ares Management, cutting an estimated $36.8M.
  • Royce & Associates fully exited Children's Place in Q3 2020, selling an estimated $11.2M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $9.27B portfolio in Q3 2020.
  • Royce & Associates opened 57 new positions and closed 245 in Q3 2020.
  • Royce & Associates's portfolio value rose 2.1% quarter-over-quarter to $9.27B.

Based on Royce & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.